OptiNose Inc - נכסים נקיים למניה בודדת OPTN

OptiNose, Inc. (OPTN) specializes in sinus therapy via the EDS system and the drug XHANCE, scaling its business through the mass production of high-margin delivery devices. The reference book value per share illustrates the net asset trend, where -6.03 captures the current value of the indicator. Positive cash flow is currently driven by sales of specialized sprays, while marketing optimization has already been priced in by the market.

The stability of component supplies for OptiNose, Inc. (OPTN) nasal drug delivery systems ensures asset resilience, which is reflected in the trend of the final book value per share. This metric is calculated as the difference between total assets and liabilities divided by the number of shares, demonstrating the actual amount of equity per share and the level of fundamental investor protection.